Air Canada
AC
Palantir Technologies Inc
PLTR
Whitecap Resources Inc
WCP
4
BCE Inc
BCE
5
Canadian Natural Resources Ltd
CNQ
CA Stock MarketDetailed Quotes
MBX Microbix Biosystems Inc
- 0.395
- +0.005+1.28%
15min DelayMarket Closed May 5 16:00 ET
55.95MMarket Cap28.21P/E (TTM)
0.410High0.385Low64.08KVolume0.385Open0.390Pre Close25.14KTurnover0.55052wk High0.05%Turnover Ratio141.64MShares0.29052wk Low0.014EPS TTM46.78MFloat Cap1.900Historical High15.19P/E (Static)118.42MShs Float0.000Historical Low0.026EPS LYR6.41%Amplitude--Dividend TTM1.94P/B1Lot Size--Div YieldTTM
Microbix Biosystems Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -40.80%792.7K | 497.20%4.35M | 152.60%765.93K | -34.15%1.4M | 179.48%839.25K | 287.56%1.34M | -131.59%-1.09M | -1,094.43%-1.46M | -21.34%2.13M | -218.21%-1.06M |
| Net income from continuing operations | -65.10%856.96K | 9,015.68%3.52M | -77.95%440.32K | 132.08%246.75K | 1,094.74%377.73K | 288.98%2.46M | -102.21%-39.48K | 530.37%2M | -220.46%-769.11K | -95.69%31.62K |
| Operating gains losses | ---- | ---166.63K | --0 | ---166.63K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 13.73%434.94K | 39.38%1.61M | 29.22%399.57K | 40.25%426.66K | 33.64%404.15K | 58.49%382.43K | 11.65%1.16M | 6.23%309.23K | 15.27%304.22K | 17.09%302.43K |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | ---3.08M | ---- | ---- | ---- |
| Remuneration paid in stock | -10.50%177.43K | -2.86%714.29K | -16.89%143.25K | -10.15%181.89K | 2.89%190.9K | 13.30%198.25K | 13.18%735.32K | -6.16%172.36K | 7.72%202.45K | 23.33%185.54K |
| Other non cashItems | 11.92%118.77K | 25.70%441.03K | 12.15%113.54K | 16.29%110.77K | 39.26%110.6K | 41.60%106.12K | 6.16%350.86K | 39.63%101.24K | 21.11%95.25K | -7.20%79.42K |
| Change In working capital | 55.89%-795.4K | -706.98%-1.77M | 65.46%-330.75K | -73.72%604.06K | 85.25%-244.14K | -2,014.60%-1.8M | 35.36%-219.84K | -1,614.59%-957.71K | 49.20%2.3M | -394.61%-1.65M |
| -Change in receivables | ---758.69K | 98.83%-12.71K | ---119.69K | --394.84K | -107.64%-600.87K | ---- | -197.35%-1.09M | ---- | ---- | -128.58%-289.38K |
| -Change in inventory | ---611.19K | -52.51%-712.38K | ---214.93K | ---92.03K | 98.31%-12.94K | ---- | 46.76%-467.11K | ---- | ---- | -55.81%-766.78K |
| -Change in prepaid assets | --20.31K | 189.02%123.98K | --146.76K | --398.51K | -354.56%-277.77K | ---- | -171.62%-139.27K | ---- | ---- | 127.73%109.12K |
| -Change in payables and accrued expense | --38.57K | 55.26%389.92K | --607.51K | --295.19K | 138.49%70.5K | ---- | 215.85%251.14K | ---- | ---- | 65.37%-183.15K |
| -Change in other working capital | --515.6K | -227.85%-1.56M | ---750.41K | ---392.45K | 209.96%576.94K | ---- | 492.80%1.22M | ---- | ---- | -880.46%-524.67K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -40.80%792.7K | 497.20%4.35M | 152.60%765.93K | -34.15%1.4M | 179.48%839.25K | 287.56%1.34M | -131.59%-1.09M | -1,094.42%-1.46M | -21.34%2.13M | -218.21%-1.06M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -453.28%-203.05K | -87.63%-1.91M | -94.72%-229.49K | -366.10%-1M | -15.75%-637.91K | 72.23%-36.7K | 49.83%-1.02M | 90.24%-117.85K | 18.72%-215.11K | -37.65%-551.11K |
| Net PPE purchase and sale | -453.28%-203.05K | -61.00%-1.64M | -94.72%-229.49K | -240.31%-732.05K | -15.75%-637.91K | 72.23%-36.7K | 49.83%-1.02M | 90.24%-117.85K | 18.72%-215.11K | -37.65%-551.11K |
| Net intangibles purchas and sale | ---- | ---270.6K | --0 | ---270.6K | ---- | ---- | --0 | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -453.28%-203.05K | -87.63%-1.91M | -94.72%-229.49K | -366.10%-1M | -15.75%-637.91K | 72.23%-36.7K | 49.83%-1.02M | 90.24%-117.85K | 18.72%-215.11K | -37.65%-551.11K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -301.12%-504.95K | -572.95%-1.08M | -67.04%-381.88K | -103.39%-465.14K | -112.30%-111.11K | 41.92%-125.88K | -88.89%229.21K | -159.26%-228.62K | 52.62%-228.69K | -25.52%903.25K |
| Net issuance payments of debt | 0.16%-73.21K | -142.16%-522.49K | -82.44%-73.33K | -312.18%-302.51K | -106.03%-73.33K | -153.76%-73.33K | 189.67%1.24M | 54.44%-40.19K | 87.51%-73.39K | 24.02%1.22M |
| Net common stock issuance | -872.81%-511.29K | 17.03%-925.28K | -67.18%-315.01K | 2.06%-162.63K | 1.26%-395.08K | 85.43%-52.56K | ---1.12M | ---188.43K | ---166.05K | ---400.11K |
| Proceeds from stock option exercised by employees | --79.55K | 245.57%363.75K | --6.45K | --0 | 310.93%357.3K | --0 | -96.94%105.26K | --0 | -89.76%10.75K | -62.51%86.95K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -301.12%-504.95K | -572.95%-1.08M | -67.04%-381.89K | -103.39%-465.14K | -112.30%-111.11K | 41.92%-125.88K | -88.89%229.21K | -159.26%-228.62K | 52.62%-228.69K | -25.52%903.25K |
| Net cash flow | ||||||||||
| Beginning cash position | 11.69%12.96M | -13.95%11.61M | -4.48%12.81M | 9.82%12.87M | 2.88%12.78M | -13.95%11.61M | 35.07%13.49M | -5.32%13.41M | -3.93%11.72M | 18.39%12.43M |
| Current changes in cash | -92.80%84.7K | 172.11%1.36M | 108.57%154.56K | -103.81%-64.31K | 112.82%90.23K | 210.69%1.18M | -153.73%-1.88M | -167.02%-1.8M | -14.00%1.69M | -141.26%-703.72K |
| End cash Position | 2.07%13.05M | 11.69%12.96M | 11.69%12.96M | -4.48%12.81M | 9.82%12.87M | 2.88%12.78M | -13.95%11.61M | -13.95%11.61M | -5.32%13.41M | -3.93%11.72M |
| Free cash from | -54.72%589.65K | 215.64%2.44M | 134.08%536.44K | -79.08%400.84K | 112.53%201.34K | 253.93%1.3M | -246.63%-2.11M | -48.37%-1.57M | -21.62%1.92M | -426.05%-1.61M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.